The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus …
A Kapur, D Bartolini, MC Finlay… - Journal of …, 2010 - journals.lww.com
Objectives The aim of the Bypass Angioplasty Revascularization in Type 1 and Type 2
Diabetes study was to assess percutaneous coronary intervention (PCI) and coronary artery …
Diabetes study was to assess percutaneous coronary intervention (PCI) and coronary artery …
Is Angioplasty Able to Become the Gold Standard of Treatment Beyond Bypass Surgery for Patients With Multivessel Coronary Artery Disease?–Therapeutic …
T Takayama, T Hiro, A Hirayama - Circulation Journal, 2010 - jstage.jst.go.jp
2745 (PCI) Angioplasty for Multivessel CAD 1,205 patients. The primary clinical endpoint in
ARTS trial was freedom from major cardiac and cerebrovascular events (MACCE) at 1 year …
ARTS trial was freedom from major cardiac and cerebrovascular events (MACCE) at 1 year …
Safety and efficacy of sirolimus-eluting stent implantation in patients with acute coronary syndrome in the real world
R Kawaguchi, T Kimura, T Morimoto, S Oshima… - The American journal of …, 2010 - Elsevier
The use of drug-eluting stents in patients with acute coronary syndrome (ACS), particularly
those with acute myocardial infarction (AMI), is controversial owing to concerns about late …
those with acute myocardial infarction (AMI), is controversial owing to concerns about late …
[PDF][PDF] Molecular basis of different outcomes for drug-eluting stents that release sirolimus or tacrolimus
A Giordano - Curr Opin Drug Discov Devel, 2010 - researchgate.net
Sirolimus and tacrolimus are potent immunosuppressants that are delivered by drug-eluting
stents (DES) for the prevention of in-stent restenosis. Balloon angioplasty with stent …
stents (DES) for the prevention of in-stent restenosis. Balloon angioplasty with stent …
Therapeutic goals in patients with refractory chronic angina
MG Cohen, M Pascual, BM Sciric, EM Ohman - Revista Española de …, 2010 - Elsevier
Refractory angina presents a major clinical challenge for everyday medical practice. Despite
the widespread use of statins and improvements in revascularization techniques, a …
the widespread use of statins and improvements in revascularization techniques, a …
Elective coronary stenting increases fractional flow reserve in other arteries due to an increase in microvascular resistance: clinical implications for assessment of …
Introduction: Fractional flow reserve (FFR) can guide percutaneous coronary intervention
(PCI) in multivessel disease (MVD). However, the effect of target vessel (TV) stenting on …
(PCI) in multivessel disease (MVD). However, the effect of target vessel (TV) stenting on …
Факторы риска рестенозов после реваскуляризации миокарда у пациентов с метаболическим синдромом и сахарным диабетом 2 типа
ГА Чумакова, НГ Веселовская… - Сердце: журнал для …, 2010 - elibrary.ru
Низкая эффективность лечения ИБС нередко связана с наличием у больных таких
ассоциированных состояний, как метаболический синдром (МС) и СД 2 типа. Около 15 …
ассоциированных состояний, как метаболический синдром (МС) и СД 2 типа. Около 15 …
Metas terapéuticas en pacientes con angina refractaria crónica
MG Cohen, M Pascual, BM Scirica… - Revista española de …, 2010 - Elsevier
La angina refractaria constituye un importante reto clínico para la medicina actual. A pesar
del amplio uso de las estatinas y del perfeccionamiento de las técnicas de …
del amplio uso de las estatinas y del perfeccionamiento de las técnicas de …